Search inquiry: <.>II=ЕУ12/2017/39/1<.> |
Total number of found documents : 29
Shown documents from 1 till 20 |
|
>1.
| Trichilemmal cystis in metastatic melanoma/I. Savarese [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.86-87
|
>2.
| The MRPS 18-2 protein as a putative marker of carcinogenesis/M. Mints [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92
|
>3.
| The impact of coloregional treatment on survival of patients with primary metastatic breast cancer/R. Liubota [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.75-77
|
>4.
| The adaptor protein Ruk/CIN85 paradoxically enhances EMT of triple negative mouse breast adenocarcinoma 4T1 cells/I. Horak [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89
|
>5.
| Satinder K. Impact of single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women/K. Satinder, R. C. Sobti, K. Pushpinder // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.69-74
|
>6.
| Parthenolide reduces gene transcription of prosurvival mediators in U937 cells/S. Mohammadi [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.30-35
|
>7.
| Materials of international vactrain/ 3-rd Swedish-Ukrainian conference on cancer diseases, January 16-17, 2017, Stockholm, Sweden // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-93
|
>8.
| Mankovska O. Identification of novel molecular and genetic markers for early detection and prognosis of epithelial tumors/O. Mankovska, V. Kashuba // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.93
|
>9.
| Kyiv, May 11-12, 2017 Workshop with international participation. New trends in cancer research and innovative tumor vaccines // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.94
|
>10.
| Kashuba E. Do MRPS 18-2 and RB proteins cooperate to control cell stemness and differentiation, preventing cancer development?/E. Kashuba, M. Mushtag // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.12-16
|
>11.
| International scientific conference "Normal and and cancer stem cells: discovery, diagnosis and therapy", October 5-6, 2017, Kyiv, Ukraine // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.95
|
>12.
| High expression levels of MRPS 18-2 and presence of the RB protein are required for the maintenance of stem cell phenotype/M. Mushtag [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92-93
|
>13.
| EPR spectroscopy studies of changes in erythrocyte membranes in patients with laryngeal cancer/Y. B. Burlaka [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.49-52
|
>14.
| Endoplasmic reticulum stress as a key factor of genome reprogramming in cancer cells/O. O. Ratushna [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-89
|
>15.
| Effect of antitumor drugs in low concentrations on the biological, immunophenotypic and cytogenetic characteristics of human colon cancer cells in vitro/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.17-24
|
>16.
| Diagnostic challenges with intraoral myeloid sarcoma/P. Kumar [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.78-85
|
>17.
| Circulating tumor cells in breast cancer/N. V. Cherdyntseva [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.2-11
|
>18.
| Chekhun V.F. Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes/V. F. Chekhun, A. V. Andriiv, N. Yu. Lukianova // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.65-68
|
>19.
| CD150/SLAMF1 as a new potential target for anti-tumor therapy/S. P. Sidorenko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90-91
|
>20.
| CD150/SLAMF1 antigen in molecular pathobiology of chronic lymphocytic leukemia/I. Gordiienko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.91-92
|
|
|